Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ribosomal protein L36a pseudogene 53 (RPL36AP53) is a pseudogene derived from the gene encoding ribosomal protein L36a, a component of the large 60S ribosomal subunit involved in protein synthesis[1][4][6]. RPL36AP53 itself does not code for a functional protein and is not known to encode any product[1][6]. There are many ribosomal protein pseudogenes in the human genome, suggesting potential regulatory functions, but no direct evidence exists for RPL36AP53 as a functional protein or drug target. Currently, it is not a recognized therapeutic target, and there are no drugs or established disease associations specific to this pseudogene[1][4][6]. It may have very limited or tissue-specific expression, as is typical for ribosomal protein pseudogenes, but its biological significance is unproven[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein L36a pseudogene 53 (RPL36AP53).